Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial
- 19 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Biostatistics
- Vol. 11 (3) , 413-418
Abstract
With the analysis of complex, messy data sets, the statistics community has recently focused attention on "reproducible research," namely research that can be readily replicated by others. One standard that has been proposed is the availability of data sets and computer code. However, in some situations, raw data cannot be disseminated for reasons of confidentiality or because the data are so messy as to make dissemination impractical. For one such situation, we propose 2 steps for reproducible research: (i) presentation of a table of data and (ii) presentation of a formula to estimate key quantities from the table of data. We illustrate this strategy in the analysis of data from the Prostate Cancer Prevention Trial, which investigated the effect of the drug finasteride versus placebo on the period prevalence of prostate cancer. With such an important result at stake, a transparent analysis was important.Keywords
This publication has 7 references indexed in Scilit:
- Reproducible research and BiostatisticsBiostatistics, 2009
- Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity AnalysisJournal of the American Statistical Association, 2008
- Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling ApproachCancer Prevention Research, 2008
- Estimating Rates of True High-Grade Disease in the Prostate Cancer Prevention TrialCancer Prevention Research, 2008
- Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariatesBiostatistics, 2005
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- The Multinomial-Poisson TransformationJournal of the Royal Statistical Society: Series D (The Statistician), 1994